Notably, in human‐like mouse post‐resection CRC models, TROP2 is highly reactivated in cell populations responsible for liver metastatic colonisation and relapses following radical operation,19 positing TROP2 as the potential driver of refractory CRLM. The gene discussed is TACSTD2; the disease is colorectal carcinoma.